PKU
2.42% of the world's population has Phenylketonuria (pku)
Phenylketonuria (PKU) is inherited when both parents are carriers of the gene. Since it is a recessive gene, there is a 25% chance that any baby conceived by two people carrying the PKU gene will have PKU.
Phenylketonuria (PKU) is not an eating disorder. It is an inherited disorder which the body cannot break down phenylalanine, which is a part of protein. If PKU is not treated soon after birth, it can cause brain and nervous system damage.
Phenylketonuria (PKU) is a rare genetic condition that is present from birth. It is a learning disability that can damage the brain.
Phenylketonuria (PKU) is a genetic disorder that causes a person to be unable to metabolize the amino acid phenylalanine. This leads to a buildup of phenylalanine in the body, which can be harmful to the brain and nervous system if not managed properly. Individuals with PKU require a strict low-phenylalanine diet to prevent complications.
Phenylketonuria (PKU) is an inborn error in metabolism that prevents the body from using phenylalanine, an amino acid necessary for normal growth and development.
It is possible for a parent with phenylketonuria to pass the condition to their offspring if both parents are carriers of the PKU gene mutation. In this case, there is a 25% chance that their child will inherit two copies of the mutated gene and develop phenylketonuria. Genetic testing can provide more information on the risk of passing PKU to offspring.
Phenylketonuria (PKU) is a condition that makes it impossible to metabolize the amino acid phenylalanine. People with PKU lack an enzyme called phenylalanine hydroxylase, which is required to break down phenylalanine. If left untreated, the buildup of phenylalanine can lead to brain damage and other neurological problems, so individuals with PKU must follow a strict low-phenylalanine diet.
Phenylketonuria (PKU) occurs in approximately 1 in 10,000 to 15,000 newborns in the United States. Screening programs help to detect PKU early so that affected individuals can receive treatment to prevent complications.
A test for phenylketonuria (PKU) is commonly done in a lot of countries. It's included in the baby's newborn screening panel. About the only reason for not testing for PKU is lack of resources of those providing care in the country, community or at the location of the baby's birth.
A person with phenylketonuria (PKU) is unable to break down the amino acid phenylalanine due to a deficiency in the enzyme phenylalanine hydroxylase. This can lead to a build-up of phenylalanine in the body, which can be toxic to the brain and nervous system if not controlled through dietary restrictions.